We are live on
!
Find out more
WT
Wellcome Trust Portfolio holdings
AUM
$9.01B
1-Year Est. Return
12.05%
This Fund
S&P 500
This Quarter
Est. Return
+1.99%
1 Year Est. Return
+12.05%
3 Year Est. Return
+59.66%
5 Year Est. Return
+58.12%
10 Year Est. Return
+403.84%
AUM
$4.85B
AUM Growth
+$25M
(+0.52%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
0.35%
Top 10 Holdings %
Top 10 Hldgs %
55.22%
Holding
30
New
–
Increased
7
Reduced
4
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$45.2M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$11.4M |
| 3 |
Bank of America
BAC
|
+$10.3M |
| 4 |
ExxonMobil
XOM
|
+$4.94M |
| 5 |
IBM
IBM
|
+$4.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$18.8M |
| 2 |
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
|
+$1.17M |
| 3 |
AKAO
Achaogen Inc
AKAO
|
+$494K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.37% |
| 2 | Technology | 22.86% |
| 3 | Communication Services | 13.56% |
| 4 | Consumer Staples | 11.23% |
| 5 | Consumer Discretionary | 8.55% |
Similar funds
A
VAS
AI
AI
HI
SFM
MIH
RWP
Wellcome Trust's Q4 2014 Portfolio in Review
As of Q4 2014, Wellcome Trust held 30 positions worth $4.85B, up 0.52% from $4.82B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Trading was light in Q4 2014: portfolio turnover was 3.3%. Wellcome Trust opened no new positions and exited 1, leaving the 30-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Communication Services.
- Wellcome Trust added most to Meta Platforms (Facebook) in Q4 2014, an estimated $45.2M increase.
- Wellcome Trust's biggest Q4 2014 reduction was Alibaba, cutting an estimated $18.8M.
- Wellcome Trust's ten largest holdings make up 55% of its $4.85B portfolio in Q4 2014.
- Wellcome Trust opened 0 new positions and closed 1 in Q4 2014.
- Wellcome Trust's portfolio value rose 0.52% quarter-over-quarter to $4.85B.
Based on Wellcome Trust's 13F filing for Q4 2014, filed 16 Jan 2015.